This Week in Psychedelics - 7.16.21

Cannabis

• Schumer, Senate Democrats unveil new bill to decriminalize marijuana (The Hill)

• Can Marijuana Make You a Better Athlete? (The New York Times)

• Missouri Man Released From Prison After Serving 11 Years for Possessing One Pound of Weed (MERRY JANE)

• Cannabis vs. HIV: UNC researcher lands $4M grant to explore possibility (WRAL Tech Wire)

• DEA Approves Denver Marijuana Facility for Medical Research (Westword)

• Tennessee Republican Lawmaker’s New Bill Would Put Three Marijuana Questions Before Voters On 2022 Ballot (Marijuana Moment)

• Michigan governor moves to regulate delta-8 THC products (Marijuana Business Daily)

• Missouri Governor Vetoes Medical Marijuana Tax Deduction Bill (Marijuana Moment)

• Analysis: Marijuana Legalization Correlates with Higher Home Values (NORML)

• Study Shows Cannabis Terpenes Provide Pain Relief, Contribute to ‘Entourage Effect’ (The University of Arizona Health Sciences)

• Cannabis may have originated in northwest China, study suggests (Henry Herald)

LSD

• Auckland University researchers to trial LSD microdoses on advanced-stage cancer patients (Newshub)

• LSD vs. Acid: A Brief History of Acid Slang (DoubleBlind)

• Calls to reclassify LSD out of class A as mental health research picks up steam (Newshub)

• Genetic Determinants of the LSD Response (Psychedelic Science Review)

Magic Mushrooms

• Psilocybin Mushrooms in Mexico in Danger of Extinction (Chacruna)

• Living In Peace: Cancer Patients Extralegally Seeking Psilocybin-Assisted Psychotherapy Amid DEA Suit (Maps of the Mind)

MDMA

• Vancouver psychedelics company gets Health Canada greenlight for MDMA therapy study (CBC)

• The Re-Emergence of Ecstasy - But Not at the Club (JD Supra)

Ayahuasca

• DMT, active component in ayahuasca, aids in the growth of new neurons (PsyPost)

• First Study on Psychedelics and Epigenetics Explores Ayahuasca’s Effects on Gene Expression (Lucid News)

• Megan Fox Said She Went To “Hell For Eternity” During A Hallucinogenic Tea Trip With Machine Gun Kelly And It “Bonded” Them Even More (BuzzFeed News)

• The Ayahuasca Experience: A Pilgrimage to the Spirit (DoubleBlind)

• Lessons From Ayahuasca (Maps of the Mind)

5-MeO-DMT

• From Hunter Biden To HGTV Star Christina Haack, Psychedelic Toad Venom Hits The Mainstream (Forbes)

Peyote

• The Traditional & Medicinal Use of Peyote in North America with Oscar Matzuwa (EntheoNation)

Iboga

• MINDCURE Announces Filing of U.S. Provisional Patent Applications for Company’s First Fully Synthetic Routes to Create an Ibogaine Psychedelic Compound (Psilocybin Alpha)

Synthetic Cannabinoids

• The Rise in Synthetic Cannabinoids and Cathinones (Psychiatric Times)

Ketamine

• Microdoses of psilocybin and ketamine enhance motivation and attention in rodent models relevant to depression (PsyPost)

• Ketamine, esketamine do not differ in cognitive effects for treatment-resistant depression (Healio)

• Dissociation as Medicine? Exploring Dissociation & Dissociative Psychedelics like Ketamine (Psychedelics Today)

• Ketamine-Assisted Psychotherapy for Frontline Workers (Truffle Report)

• Awakn Life Sciences Initiates Research Program to Further Develop Ketamine-Assisted Therapies for Treating Addiction (Psilocybin Alpha)

• Ketamine Therapy and Addiction Risk Management: Part I (Truffle Report)

• Here’s How Ketamine Affects The Brain (Healing Maps)

Miscellaneous

• California Bill To Legalize Psychedelics Possession Advances Again, With New Amendments That Add Limits (Marijuana Moment)

• In the Light of Dying Stars (Here and Now Studios)

• Ethan Nadelmann Reexamines Adult Drug Use in New Podcast ‘Psychoactive’ (Rolling Stone)

• Biden Selects White House Drug Czar Who Helped Implement State Marijuana Program And Touted Medical Benefits (Marijuana Moment)

• World Reimagined: The Growth of the Psychedelic Industry (Nasdaq)

• Syncing Psychedelic Sessions with Moon Cycles (Maps of the Mind)

• Advocacy Group Asks to Delay California Psychedelics Bill Until 2022 (Truffle Report)

• Mass. Communities Move Toward Decriminalizing Psychedelics, With Some Pushback (WGBH)

• Shamanic Ceremony Leaders Join Forces to Shape Legal Strategy through the Sacred Plant Alliance (Lucid News)

• Can Coca Leaf Avoid the Wrongs of The Psychedelic Revolution? (Chacruna)

• Religious Access to Psychedelics is No Substitute for Decriminalization (DoubleBlind)

• Is public discourse on drug overdoses improving? (Drug WarRant)

• Active vs. Passive Coping Distinguishes Antidepressants and Psychedelics (Psychedelic Science Review)

• Food Suggestions for Before, During, and After Psychedelic Sessions (Maps of the Mind)

• Ultimate Guide on the Legalization and Decriminalization of Drugs (Reality Sandwich)

• Psychedelics and Death: Transitioning from this World with Consciousness (Chacruna)

• The interesting origins of psychedelic therapy (Freethink)

• New Frontiers in the Law of Psychedelics (JD Supra)

• Psychedelic Decriminalization Creating Market Opportunities (PR Newswire)

• Going Offline for Psychedelic Journeys (Maps of the Mind)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.

This Week in Psychedelics - 11.20.20

Cannabis

• Mexican Senate Passes Bill To Legalize Marijuana Nationwide (Marijuana Moment)

• Israel Announced Intentions To Legalize Recreational Cannabis (High Times)

• Argentina redraws medical cannabis rules, allowing home cultivation (Marijuana Business Daily)

• Cannabis resin now 25% more potent, global study reveals (The Guardian)

• New Jersey Senate Approves Marijuana Decriminalization Despite Contentious Psychedelics Provision (Marijuana Moment)

• CBD is not a narcotic, says EU court as it rules French ban is illegal (The Guardian)

• Lawmakers In Wisconsin Capital Vote To Allow Marijuana Use In Public (Marijuana Moment)

• How marijuana legalization made strides across the US in this election (The Guardian)

• New Jersey Senate And Assembly Committee Pass Marijuana Sales Bills Despite Pushback From Equity Advocates (Marijuana Moment)

• New Jersey: Senate Lawmakers Approve Legislation to End Low-Level Marijuana Arrests (NORML)

LSD

• Joanna Harcourt-Smith, Lover of Timothy Leary, High Priest of LSD, Dies at 74 (The New York Times)

• MindMed Receives Approval of Protocol Design to Evaluate Microdoses of LSD For Adult ADHD In Phase 2a Clinical Trial from Swiss and Dutch Health Authorities (Psilocybin Alpha)

• Florida man on LSD tackles Disney security guard at Animal Kingdom (Orlando Weekly)

Magic Mushrooms

• First Non-Palliative Canadian Granted Access To Psilocybin Therapy (Psilocybin Alpha)

• Usona Offers Psilocybin to Eligible Researchers at No Cost (Usona Institute)

• Revive Therapeutics Announces Research Collaboration with PharmaTher for Development of Psilocybin in Cancer and Discovery of Novel Uses of Psychedelics (Psilocybin Alpha)

• Psilocybin increases the expression neuroplasticity-related genes in rats (PsyPost)

• Psilocybin for Depression Study Approved and Funded by German Government (Psilocybin Alpha)

• Pilot Study of Psilocybin-Assisted Group Therapy in Older AIDS Survivors (Psychedelic Science Review)

• Single Dose of Psilocybin Reduces Migraines for at Least 2 Weeks (Psilocybin Alpha)

• Aeruginascin Identified in Psilocybe cubensis Magic Mushrooms (Psychedelic Science Review)

• NeonMind Commences Preclinical Trial to Examine Psilocybin for Weight Loss (Psilocybin Alpha)

• How will Oregon’s new psilocybin therapy program work? (OPB)

• Numinus Announces Compassionate Access Trial of Psilocybin-Assisted Psychotherapy for Substance Use Disorders (Psilocybin Alpha)

• ACT and PcbAP for Depression – A Natural Synergy Part 2: The Technical Integration (Psychedelic Science Review)

• Field Trip Health Ltd. Announces Expansion to The Netherlands and Launch of Proprietary Truffle Program (Psilocybin Alpha)

Ketamine

• Happiness during ketamine infusion predicts treatment-resistant depression outcomes (Healio)

• Ketamine May Be Helpful in Treating Alcohol Use Disorder (Psychology Today)

• Veterans Are Using Ketamine-Assisted Psychotherapy To Help With PTSD (Green Entrepreneur)

Miscellaneous

• Vancouver proposes decriminalizing possession of small amounts of drugs (The Globe and Mail)

• Canadian Officials Respond To Psychedelics Decriminalization Petition, Saying No Legal Changes Needed (Marijuana Moment)

• UK on the Brink of a Psychedelic Therapy Revolution (Filter)

• One Simple Way Biden Could Prove He Regrets His Role in the Drug War (Slate)

• How Tripping Can Help Us Reimagine Capitalism Ahead of Psychedelic Commercialization (DoubleBlind)

• High Country: The Aspen Brain Institute examines the promising future of psychedelic-assisted therapy (The Aspen Times)

• The Oregon Model (The Baffler)

• Keys for Integrating Psychedelic Experiences (Psychedelics Today)

• Kin Spruijt: A Psychedelic Nurse in a Dutch Psychiatric Clinic (Chacruna)

• Paraphernalia Decrim Advances in DC—Just Not for Drug Sellers (Filter)

• Breaking Barriers So Psychedelic Experiences Can Become Mainstream (Forbes)

• What is the Default Mode Network? (Psychedelic Science Review)

• Avoiding Negative Experiences With Microdosing (The Third Wave)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalogue how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.

This Week in Psychedelics - 10.30.20

Cannabis

• New Zealand Marijuana Legalization Trails In Early Referendum Results, But More Votes To Be Counted (Marijuana Moment)

• New Jersey Lawmakers Approve Bill Providing Medical Marijuana Patient Insurance Benefits (Marijuana Moment)

• Study: Seniors Report Using Cannabis Products to Mitigate Symptoms Associated with Older Age (NORML)

• Mississippi Supreme Court Won’t Consider Challenge To Medical Marijuana Measure Until After Election (Marijuana Moment)

• South Dakota: Oglala Sioux Enacts Ordinance Legalizing Marijuana Use on Tribal Lands (NORML)

• New Jersey Marijuana Sales Could Start Just Weeks After Election Day Under Key Senator’s Plan (Marijuana Moment)

• Study suggests that cannabis can reduce OCD symptoms by half in short term (Hindustan Times)

• Idaho Activists Submit 2022 Medical Marijuana Initiative Following 2020 Complications (Marijuana Moment)

• Schools And NCAA Could Ban Marijuana Sponsorships Under Bill To Let Student Athletes Monetize Their Success (Marijuana Moment)

• Virginia NORML Calls for Legalization to Protect Marijuana Consumers from Potentially Tainted Products (NORML)

• South Dakota Voters Back Marijuana Legalization And Medical Cannabis Ballot Measures, Poll Finds (Marijuana Moment)

• The Music Never Stops With Jerry Garcia’s Just-Launched Cannabis Collection (Forbes)

LSD

• Killer High: Exploring the Phenomenon of LSD-Fuelled Murder (VICE)

• The psychedelics revolution has arrived in New Zealand (The Spinoff)

Magic Mushrooms

• Covid Can't Kill Mushrooms: The coronavirus has infected, but not killed, the movement to bring magic mushrooms to the masses (Rooster Magazine)

• Expanding On Psilocybin Research, John Hopkins Hoping To Hear From More Users (CBS Baltimore)

MDMA

• ‘Sorted’ for Es? Women and Ecstasy in 1990s Britain (Chacruna)

DMT

• SLU professor is authority on drug that landed him in jail (WWNY-TV)

Ayahuasca

• Ayahuasca Ceremonies and Tourism Return to Costa Rica (The Costa Rica Star)

• Studies lift the veil on psychedelic brew ayahuasca, its mental health benefits and potential to treat depression and trauma (South China Morning Post)

• Documentary looks at mystery medicine, Ayahuasca (The Leaf Online)

Mescaline

• What Is Mescaline? A Guide to this Cactus-Derived Psychedelic (DoubleBlind)

Synthetic Cannabinoids

• Synthetic cannabinoids linked to increased hospitalizations and deaths in older adults with COPD (Marijuana Business Daily)

• Synthetic Cannabis Could Disrupt The Marijuana Industry In A Big Way (Green Entrepreneur)

Ketamine

• Wearable Ketamine Delivery Device Developed As Alternative to Opioid-Based Pain Management (Lucid News)

• Ketamine Helps People Dislike Themselves Less (Psychedelic Science Review)

• Pharmather Files for FDA Orphan Drug Designation for Ketamine in Neuropathic Pain (Psilocybin Alpha)

• Can Dissociative Side Effect of “Floating” Predict Response to Ketamine in MDD? (Psychiatry Advisor)

Miscellaneous

• No Drugs Should Be Criminalized. It’s Time to Abolish the DEA. (Truthout)

• ‘Drug Free USA Forever’ Stamps Launched By DEA, Postal Service And Miss America (Marijuana Moment)

• Inside the ‘Psychedelic Exceptionalism’ Debate: Should All Drugs be Legal, or Just Pot and Psychedelics? (DoubleBlind)

• Psilocybin Group Therapy Improves Demoralization for AIDS Survivors (Chacruna)

• Children and Psychedelics: Re-examining Cultural Paradigms (Psychedelics Today)

• International study finds 79% of individuals who microdose with psychedelics report improvements in their mental health (PsyPost)

• Ketamine Meditation, Jungle Tripping and Modern-Day Shamans: Meet a ‘Psychedelic Concierge’ (VICE)

• The Role of Psychedelic Plant Medicines in Addiction Treatment (The Fix)

• A Collective Call for Accountability in Plant Medicine Experiences (Chacruna)

• Who owns psychedelics: patents and state therapeutic access laws (New Amsterdam Psychedelic Law)

• Field Trip Health Ltd. Provides Update on FT-104, Its Next Generation Psychedelic Molecule in Development (Psilocybin Alpha)

• What do Santo Daime and Raves Have in, Common? The Answer Might Move You (Chacruna)

• Journey Colab bags $3M from 'moonshot' fund to push new development model for psychedelic treatments (Fierce Biotech)

• Where Witchcraft Meets Plant Medicine (DoubleBlind)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalogue how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.